Pharmaceutical giant AstraZeneca has released images of a new £330million flagship scheme in Cambridge designed by Herzog & de Meuron
The company, which recently fought off a takeover bid from American rival Pfizer, said the proposed ‘global research & design centre’ and corporate headquarters on the Cambridge Biomedical Campus could bring up to 2,000 jobs to the city.
The highly glazed, low-rise scheme features glass walls ‘to promote visible science’ and a saw-tooth roof ‘which carries on through to the facade’.
According to the drug company, the design was inspired by ‘the unique characteristics of Cambridge’s historic centre’ and includes a central courtyard ‘reflecting the colleges of Cambridge University.’
Stefan Marbach, senior partner at Herzog & de Meuron, said: ‘The whole structure is connected in a single loop, providing short connections within the building and modern, innovative workspaces that support collaborative working. The ‘saw-tooth’ roof, which carries on through to the facade, aims to unify the appearance of the building and give it a distinctive character.’
The project will bring together AstraZeneca’s small molecule and biologics research and development activity and will also house an energy centre.
Public consultation on the designs began last week ahead of a detailed planning application in autumn this year. Construction work could be begin in early 2015 and complete the following year.
Herzog & de Meuron reveals AstraZeneca HQ